Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.

In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined. A total of 525 patients meeting DSM-III criteria for agoraphobia with panic attacks or panic disorder were randomly assigned to receive alprazolam or placebo, which they took for eight weeks. The mean daily dose at the end of the study was 5.7 mg of alprazolam or 7.5 capsules of placebo daily. Potentially serious reactions to alprazolam occurred in ten of 263 subjects who received the drug. These included acute intoxication (three), hepatitis (two), mania (two), amnesia (one), aggressive behavior (one), and depression (one). Treatment-related side effects that were worse in patients taking alprazolam than in those taking placebo included sedation, fatigue, ataxia, slurred speech, and amnesia. Sedation was the most frequent but tended to subside with dose reduction or continued administration of the drug. Patient acceptance of alprazolam, as measured by the rate of completion for study participants, was high. Eighty-four percent of patients receiving active drug completed the study compared with 50% receiving placebo.

[1]  R. Noyes,et al.  Benzodiazepine withdrawal: a review of the evidence. , 1988, The Journal of clinical psychiatry.

[2]  D. Charney,et al.  Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness. , 1986, Archives of general psychiatry.

[3]  E. Harris,et al.  Relationship between panic disorder and agoraphobia. A family study. , 1986, Archives of general psychiatry.

[4]  D. Sheehan,et al.  Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. , 1980, Archives of general psychiatry.

[5]  J. Pecknold,et al.  Alprazolam-induced manic episode in two patients with panic disorder. , 1986, The American journal of psychiatry.

[6]  D. Klein,et al.  Treatment of Phobias: I. Comparison of Imipramine Hydrochloride and Placebo , 1983 .

[7]  I. Marks Are there Anticompulsive or Antiphobic Drugs? Review of the Evidence , 1982, British Journal of Psychiatry.

[8]  R. Shader,et al.  Alprazolam-induced mania: two clinical cases. , 1985, The American journal of psychiatry.

[9]  H. Pétursson,et al.  Dependence on tranquilizers , 1984 .

[10]  A. Winston,et al.  Three case reports of acute paroxysmal excitement associated with alprazolam treatment. , 1985, The American journal of psychiatry.

[11]  A. Rifkin,et al.  Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. , 1988, Archives of general psychiatry.

[12]  R. Noyes Motor vehicle accidents related to psychiatric impairment. , 1985, Psychosomatics.

[13]  R. Noyes,et al.  Pharmacologic treatment of phobic disorders. , 1986, The Journal of clinical psychiatry.

[14]  J. Ballenger,et al.  Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. , 1987, The American journal of psychiatry.

[15]  D. Klein,et al.  Treatment of agoraphobia with group exposure in vivo and imipramine. , 1980, Archives of general psychiatry.

[16]  J. E. Groves,et al.  Emergence of hostility during alprazolam treatment. , 1984, The American journal of psychiatry.

[17]  T. Rosenthal,et al.  Anxious depressions. Clinical, family history, and naturalistic outcome--comparisons with panic and major depressive disorders. , 1984, Journal of affective disorders.

[18]  J. Price,et al.  Hypertensive Interactions Between Monoamine Oxidase Inhibitors and Foodstuffs , 1967, British Journal of Psychiatry.

[19]  D. Greenblatt,et al.  Benzodiazepines in Clinical Practice , 1974 .

[20]  D. Greenblatt,et al.  Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. , 1984, Journal of clinical psychopharmacology.

[21]  Klerman Gl,et al.  The design and conduct of the Upjohn Cross-National Collaborative Panic Study. , 1986 .

[22]  R. Swinson,et al.  Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. , 1988, Archives of general psychiatry.

[23]  P. Roy-Byrne,et al.  ALPRAZOLAM-RELATED HEPATOTOXICITY , 1983, The Lancet.